Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer (NK) cell receptors are a diverse group of cell surface proteins expressed on NK cells, which are cytotoxic lymphocytes critical to the innate immune system. These receptors regulate NK cell activity by integrating signals from both activating and inhibitory pathways, enabling NK cells to distinguish between healthy self-cells and abnormal or infected target cells. Key families include KIRs, CD94/NKG2, and NCRs. They are crucial for immune surveillance, anti-tumor and anti-viral responses.
Modulation of NK cell activation and inhibition through receptor engagement and downstream signaling cascades.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural Killer Cell Receptor.